27801847|t|Different Susceptibilities between Apoe - and Ldlr - Deficient Mice to Inflammation - Associated Colorectal Carcinogenesis
27801847|a|Hypercholesterolemia resulting in atherosclerosis is associated with an increased risk of ischemic heart disease and colorectal cancer (CRC). However, the roles of apoliprotein (Apo) E (Apoe) and low-density lipoprotein (Ldl) receptor (Ldlr) in colorectal carcinogenesis have not yet been investigated. In this study, we examined the susceptibility of Apoe - deficient and Ldlr - deficient mice, which are genetic animal models of atherosclerosis to azoxymethane (AOM)/ dextran sodium sulfate (DSS)- induced colorectal carcinogenesis. In Experiment 1, male Apoe - deficient (n = 20) and wild type (WT) mice (C57BL/6J, n = 21) were treated with a single intraperitoneal (i.p.) injection of AOM (10 mg/kg body weight) and then given 1.5% DSS in drinking water for seven days. They were maintained up to week 20 and sacrificed for the histopathological examination of colorectal tumors. The mRNA expression of cyclooxygenase (Cox)-2, inducible nitric oxide synthase (Nos2), tumor necrosis factor (Tnf)-α interleukin (Il)-1β, and Il-6 was assayed in the colorectal mucosa. In Experiment 2, male Ldlr - deficient (n = 14) and WT mice (C57BL/6J, n = 10) were given a single i.p. injection of AOM (10 mg/kg body weight) and then given 2% DSS in drinking water for seven days. They were sacrificed at week 20 to evaluate their colorectum histopathologically. In Experiment 1, the multiplicity of CRCs was significantly higher in the Apoe - deficient mice (2.75 ± 1.48) than in the WT mice (0.62 ± 0.67). The serum lipoprotein levels in the Apoe - deficient mice were also significantly higher than in the WT mice. In Experiment 2, the incidence (29%) and multiplicity (0.50 ± 0.94) of CRCs in the Ldlr mice were significantly lower than in the WT mice (80% incidence and 3.10 ± 2.38 multiplicity). The mRNA expression of two inducible enzymes and certain pro-inflammatory cytokines in the colorectum of each genotype was greater than in the respective WT mice. The values in the Apoe - deficient mice were much greater than in the Ldlr mice. These findings suggest that Apoe - deficient mice showed increased susceptibility to inflammation - associated colorectal carcinogenesis due to their high reactivity to inflammatory stimuli.
27801847	10	26	Susceptibilities	T201	C0012655
27801847	35	39	Apoe	T028	C1412481
27801847	46	50	Ldlr	T028	C1366529
27801847	53	62	Deficient	T080	C2987487
27801847	63	67	Mice	T015	C0025929
27801847	71	83	Inflammation	T046	C0021368
27801847	86	96	Associated	T080	C0332281
27801847	97	122	Colorectal Carcinogenesis	T191	C0009404
27801847	123	143	Hypercholesterolemia	T047	C0020443
27801847	157	172	atherosclerosis	T047	C0004153
27801847	176	191	associated with	T080	C0332281
27801847	195	209	increased risk	T033	C1281905
27801847	213	235	ischemic heart disease	T047	C0151744
27801847	240	257	colorectal cancer	T191	C1527249
27801847	259	262	CRC	T191	C1527249
27801847	287	307	apoliprotein (Apo) E	T116,T123	C0003595
27801847	309	313	Apoe	T116,T123	C0003595
27801847	319	357	low-density lipoprotein (Ldl) receptor	T116,T192	C0034821
27801847	359	363	Ldlr	T116,T192	C0034821
27801847	368	393	colorectal carcinogenesis	T191	C0009404
27801847	434	439	study	T062	C0008972
27801847	444	452	examined	T058	C0220825
27801847	457	471	susceptibility	T201	C0012655
27801847	475	479	Apoe	T028	C1412481
27801847	482	491	deficient	T080	C2987487
27801847	496	500	Ldlr	T116,T192	C0034821
27801847	496	500	Ldlr	T028	C1366529
27801847	503	512	deficient	T080	C2987487
27801847	513	517	mice	T015	C0025929
27801847	529	550	genetic animal models	T008	C0599779
27801847	554	569	atherosclerosis	T047	C0004153
27801847	573	585	azoxymethane	T109,T131	C0004519
27801847	587	590	AOM	T109,T131	C0004519
27801847	593	615	dextran sodium sulfate	T109,T121	C0079225
27801847	617	620	DSS	T109,T121	C0079225
27801847	623	630	induced	T046	C0007994
27801847	631	656	colorectal carcinogenesis	T191	C0009404
27801847	661	671	Experiment	T062	C0205664
27801847	680	684	Apoe	T028	C1412481
27801847	687	696	deficient	T080	C2987487
27801847	710	729	wild type (WT) mice	T015	C1520150
27801847	754	761	treated	T169	C1522326
27801847	776	808	intraperitoneal (i.p.) injection	T169	C4282146
27801847	812	815	AOM	T109,T131	C0004519
27801847	826	837	body weight	T032	C0005910
27801847	859	862	DSS	T109,T121	C0079225
27801847	866	880	drinking water	T167	C0599638
27801847	891	895	days	T079	C0439228
27801847	907	917	maintained	T169	C1314677
27801847	924	928	week	T079	C0439230
27801847	936	946	sacrificed	T078	C0681205
27801847	955	972	histopathological	T169	C0243140
27801847	988	1005	colorectal tumors	T191	C0009404
27801847	1011	1026	mRNA expression	T045	C1515670
27801847	1030	1052	cyclooxygenase (Cox)-2	T116,T126	C0387583
27801847	1064	1092	nitric oxide synthase (Nos2)	T116,T126	C1565684
27801847	1094	1123	tumor necrosis factor (Tnf)-α	T116,T129	C1456820
27801847	1124	1143	interleukin (Il)-1β	T116,T129	C0021753
27801847	1149	1153	Il-6	T116,T129	C0021760
27801847	1173	1190	colorectal mucosa	T024	C0026724
27801847	1195	1205	Experiment	T062	C0205664
27801847	1214	1218	Ldlr	T028	C1366529
27801847	1221	1230	deficient	T080	C2987487
27801847	1244	1251	WT mice	T015	C1520150
27801847	1291	1305	i.p. injection	T169	C4282146
27801847	1309	1312	AOM	T109,T131	C0004519
27801847	1323	1334	body weight	T032	C0005910
27801847	1354	1357	DSS	T109,T121	C0079225
27801847	1361	1375	drinking water	T167	C0599638
27801847	1386	1390	days	T079	C0439228
27801847	1402	1412	sacrificed	T078	C0681205
27801847	1416	1420	week	T079	C0439230
27801847	1427	1435	evaluate	T058	C0220825
27801847	1442	1452	colorectum	T023	C0229983
27801847	1477	1487	Experiment	T062	C0205664
27801847	1495	1507	multiplicity	T081	C0449822
27801847	1511	1515	CRCs	T191	C1527249
27801847	1548	1552	Apoe	T028	C1412481
27801847	1555	1564	deficient	T080	C2987487
27801847	1565	1569	mice	T015	C0025929
27801847	1596	1603	WT mice	T015	C1520150
27801847	1623	1647	serum lipoprotein levels	T059	C0582826
27801847	1655	1659	Apoe	T028	C1412481
27801847	1662	1671	deficient	T080	C2987487
27801847	1672	1676	mice	T015	C0025929
27801847	1701	1707	higher	T080	C0205250
27801847	1720	1727	WT mice	T015	C1520150
27801847	1732	1742	Experiment	T062	C0205664
27801847	1750	1759	incidence	T081	C0021149
27801847	1770	1782	multiplicity	T081	C0449822
27801847	1800	1804	CRCs	T191	C1527249
27801847	1812	1816	Ldlr	T028	C1366529
27801847	1817	1821	mice	T015	C0025929
27801847	1841	1846	lower	T081	C1611820
27801847	1859	1866	WT mice	T015	C1520150
27801847	1872	1881	incidence	T081	C0021149
27801847	1898	1910	multiplicity	T081	C0449822
27801847	1917	1932	mRNA expression	T045	C1515670
27801847	1940	1957	inducible enzymes	T116,T126	C0014442
27801847	1970	1996	pro-inflammatory cytokines	T116,T129	C0079189
27801847	2004	2014	colorectum	T023	C0229983
27801847	2023	2031	genotype	T032	C0017431
27801847	2036	2043	greater	T081	C1704243
27801847	2067	2074	WT mice	T015	C1520150
27801847	2094	2098	Apoe	T028	C1412481
27801847	2101	2110	deficient	T080	C2987487
27801847	2111	2115	mice	T015	C0025929
27801847	2146	2150	Ldlr	T028	C1366529
27801847	2151	2155	mice	T015	C0025929
27801847	2163	2171	findings	T033	C2825141
27801847	2185	2189	Apoe	T028	C1412481
27801847	2192	2201	deficient	T080	C2987487
27801847	2202	2206	mice	T015	C0025929
27801847	2214	2223	increased	T169	C0442805
27801847	2224	2238	susceptibility	T201	C0012655
27801847	2242	2254	inflammation	T046	C0021368
27801847	2257	2267	associated	T080	C0332281
27801847	2268	2293	colorectal carcinogenesis	T191	C0009404
27801847	2312	2322	reactivity	T169	C0443286
27801847	2326	2338	inflammatory	T169	C0333348
27801847	2339	2346	stimuli	T067	C0234402